pHAGE-EGFR-L858R Citations (2)
Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal
Articles Citing pHAGE-EGFR-L858R
| Articles |
|---|
| Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945. Wang Y, Hao Y, Ranieri M, Abramyan TM, Tsidilkovski L, Hollenberg M, Lopez A, Moore XTR, Sherman F, Deng J, Saribekyan H, Papoian G, Wong KK, Shum E, Poirier JT. NPJ Precis Oncol. 2025 Aug 20;9(1):294. doi: 10.1038/s41698-025-01086-2. PubMed |
| Early fibrotic niches establish tumour-permissive microenvironments. Cardoso EC, Lee H, England FJ, Cho H, Lu R, Varankar SS, Park MS, Rekhtman N, Koo BK, Simons BD, Choi J, Lee JH. Nature. 2026 May;653(8113):254-264. doi: 10.1038/s41586-026-10399-6. Epub 2026 Apr 22. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.